

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 6.87061362 |
| 2 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 6.76045356 |
| 3 | negative regulation of cell killing (GO:0031342) | 6.76045356 |
| 4 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 6.58347171 |
| 5 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 6.58347171 |
| 6 | modulation by symbiont of host immune response (GO:0052553) | 6.58347171 |
| 7 | positive regulation by symbiont of host defense response (GO:0052509) | 6.58347171 |
| 8 | modulation by symbiont of host defense response (GO:0052031) | 6.58347171 |
| 9 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 6.58347171 |
| 10 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.80873595 |
| 11 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.75498689 |
| 12 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.53243873 |
| 13 | detection of molecule of bacterial origin (GO:0032490) | 5.40573157 |
| 14 | macrophage activation involved in immune response (GO:0002281) | 5.35107711 |
| 15 | detection of other organism (GO:0098543) | 5.33709774 |
| 16 | neutrophil activation involved in immune response (GO:0002283) | 5.33536388 |
| 17 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.16187193 |
| 18 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.15837607 |
| 19 | detection of external biotic stimulus (GO:0098581) | 4.94954008 |
| 20 | detection of bacterium (GO:0016045) | 4.92951725 |
| 21 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.84477875 |
| 22 | cellular extravasation (GO:0045123) | 4.75704481 |
| 23 | response to interleukin-15 (GO:0070672) | 4.74092713 |
| 24 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.68282661 |
| 25 | leukocyte migration involved in inflammatory response (GO:0002523) | 4.61453614 |
| 26 | response to peptidoglycan (GO:0032494) | 4.57967247 |
| 27 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.57672958 |
| 28 | leukocyte aggregation (GO:0070486) | 4.53641329 |
| 29 | neutrophil activation (GO:0042119) | 4.52139437 |
| 30 | microglial cell activation (GO:0001774) | 4.49255354 |
| 31 | response to host immune response (GO:0052572) | 4.47521572 |
| 32 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.47521572 |
| 33 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.42658478 |
| 34 | respiratory burst (GO:0045730) | 4.41221068 |
| 35 | cellular response to interleukin-15 (GO:0071350) | 4.41168066 |
| 36 | negative regulation of interleukin-12 production (GO:0032695) | 4.33132367 |
| 37 | neutrophil mediated immunity (GO:0002446) | 4.30049060 |
| 38 | detection of biotic stimulus (GO:0009595) | 4.28807571 |
| 39 | regulation of gamma-delta T cell activation (GO:0046643) | 4.16726548 |
| 40 | macrophage activation (GO:0042116) | 4.12764779 |
| 41 | response to host (GO:0075136) | 4.12400046 |
| 42 | response to host defenses (GO:0052200) | 4.12400046 |
| 43 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 4.12400046 |
| 44 | granulocyte activation (GO:0036230) | 4.02729864 |
| 45 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 4.01660720 |
| 46 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.95484881 |
| 47 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.90033408 |
| 48 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.81278885 |
| 49 | myeloid cell activation involved in immune response (GO:0002275) | 3.81160918 |
| 50 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.80255056 |
| 51 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.74772452 |
| 52 | negative regulation of T cell mediated immunity (GO:0002710) | 3.69775848 |
| 53 | immunoglobulin mediated immune response (GO:0016064) | 3.64839765 |
| 54 | myeloid leukocyte mediated immunity (GO:0002444) | 3.64249003 |
| 55 | regulation of mast cell degranulation (GO:0043304) | 3.61200828 |
| 56 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.58122832 |
| 57 | cellular response to type I interferon (GO:0071357) | 3.52365144 |
| 58 | type I interferon signaling pathway (GO:0060337) | 3.52365144 |
| 59 | response to type I interferon (GO:0034340) | 3.49709098 |
| 60 | B cell receptor signaling pathway (GO:0050853) | 3.47133766 |
| 61 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.39060344 |
| 62 | dendritic cell migration (GO:0036336) | 3.34646327 |
| 63 | negative regulation of phagocytosis (GO:0050765) | 3.34146064 |
| 64 | positive regulation of mast cell activation (GO:0033005) | 3.33870577 |
| 65 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.33305130 |
| 66 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 3.31422703 |
| 67 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.30315480 |
| 68 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.30315480 |
| 69 | leukocyte degranulation (GO:0043299) | 3.27872612 |
| 70 | regulation of B cell differentiation (GO:0045577) | 3.22884169 |
| 71 | dendritic cell chemotaxis (GO:0002407) | 3.21248239 |
| 72 | regulation of leukocyte degranulation (GO:0043300) | 3.20971208 |
| 73 | regulation of T cell tolerance induction (GO:0002664) | 3.20339748 |
| 74 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.19813040 |
| 75 | germinal center formation (GO:0002467) | 3.19240454 |
| 76 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.18646428 |
| 77 | regulation of mast cell activation (GO:0033003) | 3.17294523 |
| 78 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.15413728 |
| 79 | regulation of tolerance induction (GO:0002643) | 3.14300260 |
| 80 | defense response to protozoan (GO:0042832) | 3.13139886 |
| 81 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.11939492 |
| 82 | negative regulation of type 2 immune response (GO:0002829) | 3.08893998 |
| 83 | positive regulation of interferon-alpha production (GO:0032727) | 3.06194667 |
| 84 | response to muramyl dipeptide (GO:0032495) | 3.01571735 |
| 85 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.01447555 |
| 86 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.99470619 |
| 87 | negative thymic T cell selection (GO:0045060) | 2.96827367 |
| 88 | myeloid leukocyte activation (GO:0002274) | 2.95493654 |
| 89 | negative regulation of interleukin-6 production (GO:0032715) | 2.95215979 |
| 90 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.94641245 |
| 91 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.94340373 |
| 92 | B cell mediated immunity (GO:0019724) | 2.92068825 |
| 93 | regulation of regulatory T cell differentiation (GO:0045589) | 2.91839618 |
| 94 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.91482995 |
| 95 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.91482995 |
| 96 | negative T cell selection (GO:0043383) | 2.91387397 |
| 97 | neutrophil chemotaxis (GO:0030593) | 2.90848370 |
| 98 | positive regulation of B cell differentiation (GO:0045579) | 2.90676135 |
| 99 | regulation of regulated secretory pathway (GO:1903305) | 2.90167876 |
| 100 | negative regulation of alpha-beta T cell activation (GO:0046636) | 2.86572993 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.20577522 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.96885586 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.27698099 |
| 4 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.97724030 |
| 5 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.87494123 |
| 6 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.68483356 |
| 7 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.26151509 |
| 8 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.20738196 |
| 9 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.88041447 |
| 10 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.87493364 |
| 11 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.84063975 |
| 12 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.79464527 |
| 13 | SPI1_23127762_ChIP-Seq_K562_Human | 2.75076643 |
| 14 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.74181568 |
| 15 | * RUNX_20019798_ChIP-Seq_JUKART_Human | 2.70049684 |
| 16 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.67270746 |
| 17 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.59510357 |
| 18 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.59467434 |
| 19 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.48885970 |
| 20 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.44342251 |
| 21 | MAF_26560356_Chip-Seq_TH1_Human | 2.39016220 |
| 22 | MYB_26560356_Chip-Seq_TH2_Human | 2.32575033 |
| 23 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.26248446 |
| 24 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.26205722 |
| 25 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.21654091 |
| 26 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.21242316 |
| 27 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.17984740 |
| 28 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.15143627 |
| 29 | UTX_26944678_Chip-Seq_JUKART_Human | 2.13927653 |
| 30 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.08174662 |
| 31 | MYB_26560356_Chip-Seq_TH1_Human | 2.05171658 |
| 32 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.02017610 |
| 33 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.99395422 |
| 34 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.97506009 |
| 35 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.93680086 |
| 36 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.92951971 |
| 37 | MYC_22102868_ChIP-Seq_BL_Human | 1.91707824 |
| 38 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.83565022 |
| 39 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.78675484 |
| 40 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.77241912 |
| 41 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.72973590 |
| 42 | MAF_26560356_Chip-Seq_TH2_Human | 1.72479412 |
| 43 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.71751985 |
| 44 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.68196176 |
| 45 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.62290156 |
| 46 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.61785112 |
| 47 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.61127420 |
| 48 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.59927280 |
| 49 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.56109528 |
| 50 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.55633903 |
| 51 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.49386123 |
| 52 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.49265131 |
| 53 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.48868432 |
| 54 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.47252127 |
| 55 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.42797634 |
| 56 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.42318685 |
| 57 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.40304696 |
| 58 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.37110186 |
| 59 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.36437128 |
| 60 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.36433914 |
| 61 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.36233174 |
| 62 | GATA3_26560356_Chip-Seq_TH2_Human | 1.34865746 |
| 63 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.34739250 |
| 64 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.27628838 |
| 65 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.27027557 |
| 66 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.26569659 |
| 67 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.25102373 |
| 68 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.24350603 |
| 69 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.23762327 |
| 70 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.23409233 |
| 71 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.22048727 |
| 72 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.20191517 |
| 73 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.18628400 |
| 74 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.17427960 |
| 75 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.15976684 |
| 76 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.15194316 |
| 77 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.13976501 |
| 78 | GATA1_19941826_ChIP-Seq_K562_Human | 1.13083497 |
| 79 | GATA1_22025678_ChIP-Seq_K562_Human | 1.12880761 |
| 80 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.11083740 |
| 81 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.10850554 |
| 82 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.09475949 |
| 83 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.07883609 |
| 84 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.07531209 |
| 85 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.07114158 |
| 86 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.06605222 |
| 87 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.06387376 |
| 88 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.00857130 |
| 89 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.99832946 |
| 90 | GATA2_19941826_ChIP-Seq_K562_Human | 0.96907274 |
| 91 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.94144835 |
| 92 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.89940395 |
| 93 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.86418755 |
| 94 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.85841716 |
| 95 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.85651177 |
| 96 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.82282527 |
| 97 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.82032582 |
| 98 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.80956350 |
| 99 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.80754975 |
| 100 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.79523174 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003724_increased_susceptibility_to | 5.83050437 |
| 2 | MP0003436_decreased_susceptibility_to | 4.37313344 |
| 3 | MP0003303_peritoneal_inflammation | 3.88175386 |
| 4 | MP0001835_abnormal_antigen_presentation | 3.58287881 |
| 5 | MP0002419_abnormal_innate_immunity | 3.21059191 |
| 6 | MP0005025_abnormal_response_to | 2.87895159 |
| 7 | MP0001800_abnormal_humoral_immune | 2.84223151 |
| 8 | MP0009785_altered_susceptibility_to | 2.80753297 |
| 9 | MP0005671_abnormal_response_to | 2.74629072 |
| 10 | MP0000685_abnormal_immune_system | 2.73833707 |
| 11 | MP0005000_abnormal_immune_tolerance | 2.69434491 |
| 12 | MP0003191_abnormal_cellular_cholesterol | 2.65117280 |
| 13 | MP0005387_immune_system_phenotype | 2.64700688 |
| 14 | MP0001790_abnormal_immune_system | 2.64700688 |
| 15 | MP0002723_abnormal_immune_serum | 2.54445355 |
| 16 | MP0002420_abnormal_adaptive_immunity | 2.51013064 |
| 17 | MP0001819_abnormal_immune_cell | 2.48382772 |
| 18 | MP0008260_abnormal_autophagy | 2.48324106 |
| 19 | MP0006082_CNS_inflammation | 2.44791705 |
| 20 | MP0003300_gastrointestinal_ulcer | 2.43635637 |
| 21 | MP0002452_abnormal_antigen_presenting | 2.40601429 |
| 22 | MP0002132_abnormal_respiratory_system | 2.27614116 |
| 23 | MP0001533_abnormal_skeleton_physiology | 2.24288163 |
| 24 | MP0002148_abnormal_hypersensitivity_rea | 2.05534019 |
| 25 | MP0003763_abnormal_thymus_physiology | 2.05506975 |
| 26 | MP0002405_respiratory_system_inflammati | 2.05347546 |
| 27 | MP0003828_pulmonary_edema | 1.98595320 |
| 28 | MP0005464_abnormal_platelet_physiology | 1.96529370 |
| 29 | MP0005451_abnormal_body_composition | 1.92738820 |
| 30 | MP0002277_abnormal_respiratory_mucosa | 1.91632354 |
| 31 | MP0002398_abnormal_bone_marrow | 1.90242595 |
| 32 | MP0000716_abnormal_immune_system | 1.86305095 |
| 33 | MP0002396_abnormal_hematopoietic_system | 1.82346316 |
| 34 | MP0004381_abnormal_hair_follicle | 1.81657043 |
| 35 | MP0003866_abnormal_defecation | 1.72257023 |
| 36 | MP0000465_gastrointestinal_hemorrhage | 1.71090193 |
| 37 | MP0001845_abnormal_inflammatory_respons | 1.69401109 |
| 38 | MP0010155_abnormal_intestine_physiology | 1.68117440 |
| 39 | MP0003172_abnormal_lysosome_physiology | 1.67577828 |
| 40 | MP0004883_abnormal_blood_vessel | 1.66082275 |
| 41 | MP0009278_abnormal_bone_marrow | 1.64524899 |
| 42 | MP0002722_abnormal_immune_system | 1.57895382 |
| 43 | MP0003183_abnormal_peptide_metabolism | 1.55523798 |
| 44 | MP0000689_abnormal_spleen_morphology | 1.55158322 |
| 45 | MP0004947_skin_inflammation | 1.54553632 |
| 46 | MP0009764_decreased_sensitivity_to | 1.51761023 |
| 47 | MP0000703_abnormal_thymus_morphology | 1.46912455 |
| 48 | MP0002429_abnormal_blood_cell | 1.46593670 |
| 49 | MP0000858_altered_metastatic_potential | 1.43242434 |
| 50 | MP0008469_abnormal_protein_level | 1.40482385 |
| 51 | MP0009333_abnormal_splenocyte_physiolog | 1.37852939 |
| 52 | MP0005164_abnormal_response_to | 1.30975217 |
| 53 | MP0005310_abnormal_salivary_gland | 1.27622328 |
| 54 | MP0001851_eye_inflammation | 1.27346861 |
| 55 | MP0003075_altered_response_to | 1.21965471 |
| 56 | MP0001545_abnormal_hematopoietic_system | 1.20728736 |
| 57 | MP0005397_hematopoietic_system_phenotyp | 1.20728736 |
| 58 | MP0002998_abnormal_bone_remodeling | 1.10999063 |
| 59 | MP0003690_abnormal_glial_cell | 1.09846912 |
| 60 | MP0004510_myositis | 1.06090557 |
| 61 | MP0002166_altered_tumor_susceptibility | 0.99985309 |
| 62 | MP0005075_abnormal_melanosome_morpholog | 0.94247186 |
| 63 | MP0005166_decreased_susceptibility_to | 0.93559471 |
| 64 | MP0000569_abnormal_digit_pigmentation | 0.92841486 |
| 65 | MP0005390_skeleton_phenotype | 0.88958451 |
| 66 | MP0003045_fibrosis | 0.88163122 |
| 67 | MP0003448_altered_tumor_morphology | 0.86462223 |
| 68 | MP0003221_abnormal_cardiomyocyte_apopto | 0.85069206 |
| 69 | MP0000015_abnormal_ear_pigmentation | 0.84944170 |
| 70 | MP0009763_increased_sensitivity_to | 0.79650137 |
| 71 | MP0001663_abnormal_digestive_system | 0.79388111 |
| 72 | MP0008004_abnormal_stomach_pH | 0.78357189 |
| 73 | MP0004808_abnormal_hematopoietic_stem | 0.76213497 |
| 74 | MP0000343_altered_response_to | 0.75776548 |
| 75 | MP0003656_abnormal_erythrocyte_physiolo | 0.74969288 |
| 76 | MP0005377_hearing/vestibular/ear_phenot | 0.74855566 |
| 77 | MP0003878_abnormal_ear_physiology | 0.74855566 |
| 78 | MP0000490_abnormal_crypts_of | 0.73436331 |
| 79 | MP0004130_abnormal_muscle_cell | 0.70453876 |
| 80 | MP0004858_abnormal_nervous_system | 0.69358831 |
| 81 | MP0000604_amyloidosis | 0.68551334 |
| 82 | MP0008874_decreased_physiological_sensi | 0.67917768 |
| 83 | MP0002332_abnormal_exercise_endurance | 0.67738983 |
| 84 | MP0005248_abnormal_Harderian_gland | 0.65430830 |
| 85 | MP0002928_abnormal_bile_duct | 0.64674928 |
| 86 | MP0009765_abnormal_xenobiotic_induced | 0.63808241 |
| 87 | MP0001958_emphysema | 0.63031245 |
| 88 | MP0005388_respiratory_system_phenotype | 0.62999294 |
| 89 | MP0002133_abnormal_respiratory_system | 0.62999294 |
| 90 | MP0000249_abnormal_blood_vessel | 0.62488190 |
| 91 | MP0003795_abnormal_bone_structure | 0.62010263 |
| 92 | MP0004484_altered_response_of | 0.61119908 |
| 93 | MP0001986_abnormal_taste_sensitivity | 0.60160368 |
| 94 | MP0002006_tumorigenesis | 0.56879975 |
| 95 | MP0002933_joint_inflammation | 0.55687987 |
| 96 | MP0005083_abnormal_biliary_tract | 0.55684860 |
| 97 | MP0001853_heart_inflammation | 0.54123530 |
| 98 | MP0005319_abnormal_enzyme/_coenzyme | 0.52937132 |
| 99 | MP0003806_abnormal_nucleotide_metabolis | 0.52466504 |
| 100 | MP0001873_stomach_inflammation | 0.51815858 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 7.13449828 |
| 2 | Myositis (HP:0100614) | 6.39325924 |
| 3 | Recurrent abscess formation (HP:0002722) | 6.34984972 |
| 4 | Recurrent bacterial skin infections (HP:0005406) | 6.24041071 |
| 5 | Orchitis (HP:0100796) | 6.20808427 |
| 6 | Optic neuritis (HP:0100653) | 5.78501851 |
| 7 | Retrobulbar optic neuritis (HP:0100654) | 5.78501851 |
| 8 | Abnormality of macrophages (HP:0004311) | 5.34310481 |
| 9 | Recurrent gram-negative bacterial infections (HP:0005420) | 5.28319327 |
| 10 | Stomatitis (HP:0010280) | 5.08116443 |
| 11 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.78087241 |
| 12 | Hypochromic microcytic anemia (HP:0004840) | 4.73010430 |
| 13 | Gastrointestinal infarctions (HP:0005244) | 4.70443248 |
| 14 | Recurrent fungal infections (HP:0002841) | 4.28862098 |
| 15 | Chronic obstructive pulmonary disease (HP:0006510) | 4.26798401 |
| 16 | Obstructive lung disease (HP:0006536) | 4.26798401 |
| 17 | Keratoconjunctivitis sicca (HP:0001097) | 4.24488489 |
| 18 | Mediastinal lymphadenopathy (HP:0100721) | 4.12116250 |
| 19 | Recurrent skin infections (HP:0001581) | 4.03684193 |
| 20 | Meningitis (HP:0001287) | 4.02740326 |
| 21 | Spontaneous hematomas (HP:0007420) | 4.02111656 |
| 22 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.99803403 |
| 23 | Keratoconjunctivitis (HP:0001096) | 3.92652407 |
| 24 | Encephalitis (HP:0002383) | 3.90289219 |
| 25 | Gingivitis (HP:0000230) | 3.85802106 |
| 26 | Hypochromic anemia (HP:0001931) | 3.79958738 |
| 27 | Peritonitis (HP:0002586) | 3.68677750 |
| 28 | Urticaria (HP:0001025) | 3.67727005 |
| 29 | Increased IgE level (HP:0003212) | 3.65138814 |
| 30 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.50980436 |
| 31 | Recurrent cutaneous fungal infections (HP:0011370) | 3.50980436 |
| 32 | Vasculitis (HP:0002633) | 3.48123733 |
| 33 | Chest pain (HP:0100749) | 3.44064865 |
| 34 | Episodic fever (HP:0001954) | 3.34939222 |
| 35 | Cellulitis (HP:0100658) | 3.30869937 |
| 36 | Prolonged bleeding time (HP:0003010) | 3.28619840 |
| 37 | T lymphocytopenia (HP:0005403) | 3.25684073 |
| 38 | Gingival bleeding (HP:0000225) | 3.18889431 |
| 39 | Abnormality of T cell number (HP:0011839) | 3.13524855 |
| 40 | Hemoptysis (HP:0002105) | 3.11690395 |
| 41 | Arterial thrombosis (HP:0004420) | 3.10147493 |
| 42 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 3.04213692 |
| 43 | Anorexia (HP:0002039) | 2.99503367 |
| 44 | Pulmonary infiltrates (HP:0002113) | 2.90596767 |
| 45 | Leukocytosis (HP:0001974) | 2.87658272 |
| 46 | Pulmonary embolism (HP:0002204) | 2.86782396 |
| 47 | Microcytic anemia (HP:0001935) | 2.84032302 |
| 48 | Epistaxis (HP:0000421) | 2.73309739 |
| 49 | Amyloidosis (HP:0011034) | 2.68454170 |
| 50 | Abnormality of T cells (HP:0002843) | 2.65809062 |
| 51 | Inflammation of the large intestine (HP:0002037) | 2.64512259 |
| 52 | Abnormality of the peritoneum (HP:0002585) | 2.56535437 |
| 53 | Osteomyelitis (HP:0002754) | 2.55725359 |
| 54 | Gastrointestinal inflammation (HP:0004386) | 2.54802275 |
| 55 | Granulocytopenia (HP:0001913) | 2.47590902 |
| 56 | Pustule (HP:0200039) | 2.46625175 |
| 57 | Sepsis (HP:0100806) | 2.46032642 |
| 58 | Increased IgM level (HP:0003496) | 2.45285146 |
| 59 | Recurrent viral infections (HP:0004429) | 2.45188588 |
| 60 | Gangrene (HP:0100758) | 2.42498386 |
| 61 | Abnormality of the pleura (HP:0002103) | 2.41762577 |
| 62 | Subacute progressive viral hepatitis (HP:0006572) | 2.37881489 |
| 63 | Petechiae (HP:0000967) | 2.29962084 |
| 64 | Abnormality of the endocardium (HP:0004306) | 2.27511516 |
| 65 | Lymphopenia (HP:0001888) | 2.24074693 |
| 66 | Panhypogammaglobulinemia (HP:0003139) | 2.22110845 |
| 67 | Slow saccadic eye movements (HP:0000514) | 2.19874978 |
| 68 | Glomerulopathy (HP:0100820) | 2.19083066 |
| 69 | Abnormality of T cell physiology (HP:0011840) | 2.18278510 |
| 70 | Keratitis (HP:0000491) | 2.16848153 |
| 71 | Abnormal platelet volume (HP:0011876) | 2.14751171 |
| 72 | Acute hepatic failure (HP:0006554) | 2.13045895 |
| 73 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.12252838 |
| 74 | Abnormality of the pericardium (HP:0001697) | 2.12057928 |
| 75 | Eosinophilia (HP:0001880) | 2.11441170 |
| 76 | Acne (HP:0001061) | 2.11004773 |
| 77 | Hypergammaglobulinemia (HP:0010702) | 2.10733526 |
| 78 | Toxemia of pregnancy (HP:0100603) | 2.08652085 |
| 79 | Skin ulcer (HP:0200042) | 2.08269888 |
| 80 | Viral hepatitis (HP:0006562) | 2.07323853 |
| 81 | Polycythemia (HP:0001901) | 2.03879845 |
| 82 | Difficulty running (HP:0009046) | 2.03843765 |
| 83 | Vertigo (HP:0002321) | 2.02831915 |
| 84 | Metaphyseal cupping (HP:0003021) | 1.99799688 |
| 85 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.98222829 |
| 86 | Premature loss of primary teeth (HP:0006323) | 1.92115743 |
| 87 | IgM deficiency (HP:0002850) | 1.89663179 |
| 88 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.86274205 |
| 89 | Chronic otitis media (HP:0000389) | 1.85880445 |
| 90 | Cheilitis (HP:0100825) | 1.85194473 |
| 91 | Hepatosplenomegaly (HP:0001433) | 1.83690208 |
| 92 | Colitis (HP:0002583) | 1.83081379 |
| 93 | Thrombophlebitis (HP:0004418) | 1.82047227 |
| 94 | Recurrent pneumonia (HP:0006532) | 1.81857130 |
| 95 | Purpura (HP:0000979) | 1.78952041 |
| 96 | Hypermelanotic macule (HP:0001034) | 1.78299224 |
| 97 | Recurrent bronchitis (HP:0002837) | 1.77538640 |
| 98 | Abnormality of eosinophils (HP:0001879) | 1.75227530 |
| 99 | Skin rash (HP:0000988) | 1.74058229 |
| 100 | Polyneuropathy (HP:0001271) | 1.72342654 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 4.86191769 |
| 2 | IRAK4 | 3.52337084 |
| 3 | MAP4K1 | 3.33885608 |
| 4 | MAP2K3 | 3.25128051 |
| 5 | BLK | 3.11838796 |
| 6 | ERN1 | 2.95450016 |
| 7 | CSK | 2.91396446 |
| 8 | TYK2 | 2.74326125 |
| 9 | EPHB1 | 2.62859553 |
| 10 | FES | 2.61070912 |
| 11 | GRK6 | 2.43470573 |
| 12 | TNK2 | 2.36080197 |
| 13 | ZAP70 | 2.02743141 |
| 14 | TAOK1 | 1.99478701 |
| 15 | MAP3K3 | 1.94424021 |
| 16 | FGR | 1.85593833 |
| 17 | HCK | 1.85089399 |
| 18 | JAK3 | 1.79290895 |
| 19 | BTK | 1.77850614 |
| 20 | MAP3K11 | 1.69796784 |
| 21 | TXK | 1.68099315 |
| 22 | PRPF4B | 1.64910691 |
| 23 | KSR2 | 1.59222416 |
| 24 | JAK2 | 1.53738793 |
| 25 | SYK | 1.53036386 |
| 26 | YES1 | 1.50655640 |
| 27 | IKBKE | 1.42800812 |
| 28 | MAP3K1 | 1.41168256 |
| 29 | LYN | 1.34632935 |
| 30 | MAP3K14 | 1.27463897 |
| 31 | JAK1 | 1.23337559 |
| 32 | TAOK3 | 1.23163490 |
| 33 | SIK3 | 1.20932571 |
| 34 | IRAK1 | 1.19910208 |
| 35 | PTK6 | 1.15567938 |
| 36 | MARK2 | 1.12313418 |
| 37 | LCK | 1.10433261 |
| 38 | MAP3K2 | 1.09259118 |
| 39 | TBK1 | 1.07227967 |
| 40 | IRAK2 | 1.05253211 |
| 41 | MAP3K13 | 1.00084811 |
| 42 | MARK3 | 0.97675526 |
| 43 | PRKD2 | 0.96646928 |
| 44 | CDK19 | 0.95567242 |
| 45 | CSF1R | 0.95287887 |
| 46 | ITK | 0.95212280 |
| 47 | MAP3K6 | 0.93282766 |
| 48 | PTK2B | 0.92509652 |
| 49 | LRRK2 | 0.91718361 |
| 50 | MATK | 0.89680177 |
| 51 | STK10 | 0.88630520 |
| 52 | TRIB3 | 0.86724054 |
| 53 | PDK1 | 0.85190209 |
| 54 | MAP2K4 | 0.85088950 |
| 55 | KIT | 0.84507410 |
| 56 | SMG1 | 0.81102753 |
| 57 | TGFBR2 | 0.79620130 |
| 58 | TEC | 0.78627805 |
| 59 | TAOK2 | 0.74929679 |
| 60 | PDPK1 | 0.74673765 |
| 61 | STK11 | 0.73430765 |
| 62 | FGFR3 | 0.72943195 |
| 63 | SIK2 | 0.72814503 |
| 64 | DYRK1B | 0.72121292 |
| 65 | MAP3K7 | 0.70354124 |
| 66 | FYN | 0.69998050 |
| 67 | PIK3CG | 0.69454576 |
| 68 | STK38 | 0.69125097 |
| 69 | EPHA3 | 0.68119734 |
| 70 | TESK2 | 0.67695846 |
| 71 | RAF1 | 0.67232535 |
| 72 | FGFR4 | 0.66205172 |
| 73 | BMPR2 | 0.65815661 |
| 74 | SGK3 | 0.65673402 |
| 75 | MAP3K5 | 0.65421534 |
| 76 | KSR1 | 0.63917008 |
| 77 | NLK | 0.54362166 |
| 78 | IKBKB | 0.52608624 |
| 79 | RET | 0.52488913 |
| 80 | WNK1 | 0.50276947 |
| 81 | MAPK12 | 0.50106947 |
| 82 | SGK2 | 0.49666463 |
| 83 | HIPK2 | 0.49616156 |
| 84 | PRKCQ | 0.47538124 |
| 85 | MAP2K6 | 0.44706692 |
| 86 | CDC42BPA | 0.43481068 |
| 87 | PRKG2 | 0.43075629 |
| 88 | PIM1 | 0.42774477 |
| 89 | DAPK2 | 0.41665209 |
| 90 | DYRK3 | 0.39569812 |
| 91 | RPS6KC1 | 0.39293736 |
| 92 | RPS6KL1 | 0.39293736 |
| 93 | MAPKAPK2 | 0.39091692 |
| 94 | PRKCZ | 0.38343063 |
| 95 | MAPK7 | 0.37773387 |
| 96 | SIK1 | 0.37012222 |
| 97 | RPS6KA6 | 0.33396012 |
| 98 | CAMKK1 | 0.30320258 |
| 99 | ALK | 0.30072577 |
| 100 | MAP3K8 | 0.27181197 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Osteoclast differentiation_Homo sapiens_hsa04380 | 3.12291763 |
| 2 | Leishmaniasis_Homo sapiens_hsa05140 | 3.05005697 |
| 3 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.72331492 |
| 4 | * Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.42586864 |
| 5 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 2.34500931 |
| 6 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.29557833 |
| 7 | Tuberculosis_Homo sapiens_hsa05152 | 2.21297050 |
| 8 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.05984772 |
| 9 | Malaria_Homo sapiens_hsa05144 | 2.04871944 |
| 10 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.01948538 |
| 11 | Allograft rejection_Homo sapiens_hsa05330 | 1.92616583 |
| 12 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.90031802 |
| 13 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.87507491 |
| 14 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.83454604 |
| 15 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.82606562 |
| 16 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.82531950 |
| 17 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.81862029 |
| 18 | * Measles_Homo sapiens_hsa05162 | 1.77587036 |
| 19 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.64608823 |
| 20 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.58914016 |
| 21 | Legionellosis_Homo sapiens_hsa05134 | 1.54216375 |
| 22 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.50854886 |
| 23 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.50250493 |
| 24 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.49291869 |
| 25 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.46438074 |
| 26 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.44661734 |
| 27 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.44276322 |
| 28 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.44190630 |
| 29 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.43545112 |
| 30 | Phagosome_Homo sapiens_hsa04145 | 1.43344239 |
| 31 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.39950311 |
| 32 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.39879975 |
| 33 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.37775760 |
| 34 | * Influenza A_Homo sapiens_hsa05164 | 1.36686936 |
| 35 | Viral myocarditis_Homo sapiens_hsa05416 | 1.33953452 |
| 36 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.33419529 |
| 37 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.26619914 |
| 38 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.24219368 |
| 39 | Hepatitis B_Homo sapiens_hsa05161 | 1.22222402 |
| 40 | Platelet activation_Homo sapiens_hsa04611 | 1.21119711 |
| 41 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.18892008 |
| 42 | Hepatitis C_Homo sapiens_hsa05160 | 1.17970084 |
| 43 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.13841070 |
| 44 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.11539426 |
| 45 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.07401983 |
| 46 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.06832208 |
| 47 | Shigellosis_Homo sapiens_hsa05131 | 1.00565061 |
| 48 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.98767876 |
| 49 | Salmonella infection_Homo sapiens_hsa05132 | 0.97217819 |
| 50 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.95298892 |
| 51 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.93985113 |
| 52 | Endocytosis_Homo sapiens_hsa04144 | 0.92148526 |
| 53 | Pertussis_Homo sapiens_hsa05133 | 0.89048756 |
| 54 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.87462863 |
| 55 | * Apoptosis_Homo sapiens_hsa04210 | 0.87169534 |
| 56 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.85120662 |
| 57 | Endometrial cancer_Homo sapiens_hsa05213 | 0.84442441 |
| 58 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.81140540 |
| 59 | * Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.80879924 |
| 60 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.79886952 |
| 61 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.79490197 |
| 62 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.77719183 |
| 63 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.75769750 |
| 64 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.75096318 |
| 65 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.74496179 |
| 66 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.71196455 |
| 67 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.69905116 |
| 68 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.69529392 |
| 69 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.69496219 |
| 70 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.69429560 |
| 71 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.68892830 |
| 72 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.68884977 |
| 73 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.68483408 |
| 74 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.67366931 |
| 75 | Amoebiasis_Homo sapiens_hsa05146 | 0.66071851 |
| 76 | Colorectal cancer_Homo sapiens_hsa05210 | 0.64014882 |
| 77 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.63986716 |
| 78 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.63449987 |
| 79 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.62613058 |
| 80 | Other glycan degradation_Homo sapiens_hsa00511 | 0.61724347 |
| 81 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.61404561 |
| 82 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.61130369 |
| 83 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.60346685 |
| 84 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.59988725 |
| 85 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.59410035 |
| 86 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.59381718 |
| 87 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.56264323 |
| 88 | Insulin resistance_Homo sapiens_hsa04931 | 0.55838954 |
| 89 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.54810247 |
| 90 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.52565782 |
| 91 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.51585684 |
| 92 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.48565265 |
| 93 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.48321405 |
| 94 | HTLV-I infection_Homo sapiens_hsa05166 | 0.47641474 |
| 95 | Prostate cancer_Homo sapiens_hsa05215 | 0.46324301 |
| 96 | Asthma_Homo sapiens_hsa05310 | 0.45703123 |
| 97 | Glioma_Homo sapiens_hsa05214 | 0.45629670 |
| 98 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.44148969 |
| 99 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.43875496 |
| 100 | Lysosome_Homo sapiens_hsa04142 | 0.43866744 |

